Guinea Pig as a Model of Infectious Diseases
The words 'guinea pig' are synonymous with scientific experimentation, but much less is known about this species than many other laboratory animals. This animal model has been used for approximately 200 y and was the first to be used in the study of infectious diseases such as tuberculosis...
Saved in:
| Published in | Comparative medicine Vol. 58; no. 4; pp. 324 - 340 |
|---|---|
| Main Authors | , , |
| Format | Journal Article |
| Language | English |
| Published |
United States
American Association for Laboratory Animal Science
01.08.2008
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | The words 'guinea pig' are synonymous with scientific experimentation, but much less is known about this species than many other laboratory animals. This animal model has been used for approximately 200 y and was the first to be used in the study of infectious diseases such as tuberculosis and diphtheria. Today the guinea pig is used as a model for a number of infectious bacterial diseases, including pulmonary, sexually transmitted, ocular and aural, gastrointestinal, and other infections that threaten the lives of humans. Most studies on the immune response to these diseases, with potential therapies and vaccines, have been conducted in animal models (for example, mouse) that may have less similarity to humans because of the large number of immunologic reagents available for these other species. This review presents some of the diseases for which the guinea pig is regarded as the premier model to study infections because of its similarity to humans with regard to symptoms and immune response. Furthermore, for diseases in which guinea pigs share parallel pathogenesis of disease with humans, they are potentially the best animal model for designing treatments and vaccines. Future studies of immune regulation of these diseases, novel therapies, and preventative measures require the development of new immunologic reagents designed specifically for the guinea pig. |
|---|---|
| AbstractList | The words 'guinea pig' are synonymous with scientific experimentation, but much less is known about this species than many other laboratory animals. This animal model has been used for approximately 200 y and was the first to be used in the study of infectious diseases such as tuberculosis and diphtheria. Today the guinea pig is used as a model for a number of infectious bacterial diseases, including pulmonary, sexually transmitted, ocular and aural, gastrointestinal, and other infections that threaten the lives of humans. Most studies on the immune response to these diseases, with potential therapies and vaccines, have been conducted in animal models (for example, mouse) that may have less similarity to humans because of the large number of immunologic reagents available for these other species. This review presents some of the diseases for which the guinea pig is regarded as the premier model to study infections because of its similarity to humans with regard to symptoms and immune response. Furthermore, for diseases in which guinea pigs share parallel pathogenesis of disease with humans, they are potentially the best animal model for designing treatments and vaccines. Future studies of immune regulation of these diseases, novel therapies, and preventative measures require the development of new immunologic reagents designed specifically for the guinea pig. The words 'guinea pig' are synonymous with scientific experimentation, but much less is known about this species than many other laboratory animals. This animal model has been used for approximately 200 y and was the first to be used in the study of infectious diseases such as tuberculosis and diphtheria. Today the guinea pig is used as a model for a number of infectious bacterial diseases, including pulmonary, sexually transmitted, ocular and aural, gastrointestinal, and other infections that threaten the lives of humans. Most studies on the immune response to these diseases, with potential therapies and vaccines, have been conducted in animal models (for example, mouse) that may have less similarity to humans because of the large number of immunologic reagents available for these other species. This review presents some of the diseases for which the guinea pig is regarded as the premier model to study infections because of its similarity to humans with regard to symptoms and immune response. Furthermore, for diseases in which guinea pigs share parallel pathogenesis of disease with humans, they are potentially the best animal model for designing treatments and vaccines. Future studies of immune regulation of these diseases, novel therapies, and preventative measures require the development of new immunologic reagents designed specifically for the guinea pig. The words 'guinea pig' are synonymous with scientific experimentation, but much less is known about this species than many other laboratory animals. This animal model has been used for approximately 200 y and was the first to be used in the study of infectious diseases such as tuberculosis and diphtheria. Today the guinea pig is used as a model for a number of infectious bacterial diseases, including pulmonary, sexually transmitted, ocular and aural, gastrointestinal, and other infections that threaten the lives of humans. Most studies on the immune response to these diseases, with potential therapies and vaccines, have been conducted in animal models (for example, mouse) that may have less similarity to humans because of the large number of immunologic reagents available for these other species. This review presents some of the diseases for which the guinea pig is regarded as the premier model to study infections because of its similarity to humans with regard to symptoms and immune response. Furthermore, for diseases in which guinea pigs share parallel pathogenesis of disease with humans, they are potentially the best animal model for designing treatments and vaccines. Future studies of immune regulation of these diseases, novel therapies, and preventative measures require the development of new immunologic reagents designed specifically for the guinea pig.The words 'guinea pig' are synonymous with scientific experimentation, but much less is known about this species than many other laboratory animals. This animal model has been used for approximately 200 y and was the first to be used in the study of infectious diseases such as tuberculosis and diphtheria. Today the guinea pig is used as a model for a number of infectious bacterial diseases, including pulmonary, sexually transmitted, ocular and aural, gastrointestinal, and other infections that threaten the lives of humans. Most studies on the immune response to these diseases, with potential therapies and vaccines, have been conducted in animal models (for example, mouse) that may have less similarity to humans because of the large number of immunologic reagents available for these other species. This review presents some of the diseases for which the guinea pig is regarded as the premier model to study infections because of its similarity to humans with regard to symptoms and immune response. Furthermore, for diseases in which guinea pigs share parallel pathogenesis of disease with humans, they are potentially the best animal model for designing treatments and vaccines. Future studies of immune regulation of these diseases, novel therapies, and preventative measures require the development of new immunologic reagents designed specifically for the guinea pig. |
| Author | Padilla-Carlin, Danielle J McMurray, David N Hickey, Anthony J |
| Author_xml | – sequence: 1 fullname: Padilla-Carlin, Danielle J – sequence: 2 fullname: McMurray, David N – sequence: 3 fullname: Hickey, Anthony J |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/18724774$$D View this record in MEDLINE/PubMed |
| BookMark | eNqFkc1O3TAQhbMAlZ_2FdqsuuJKY8eJnQ0CQUuRqKjUsh5N7ElqlGtDnCC1T48vFyq6qOqNRzpHn86cOSh2Qgy8U-yLupIrMBL2ioOUbgFk24J8U-wJo6XSWu0XRxeLD0zlNz-UlEoqv0bHYxn78jL0bGcfl1Se-8SUOL0tdnsaE797_g-Lm8-ffpx9WV1dX1yenV6teqXMvNJKaFkJ5zpJRgkHzMoatl3TSWfarmuE4yzLmrgVTktqwXbcgbaWc7TqsDjecu-Wbs3OcpgnGvFu8muafmEkj38rwf_EIT6g1NCAqjLg4zNgivcLpxnXPlkeRwqcF8KmVY1QAv5rVEZIY3Sdje9fR_qT5aXJbLjeGnwYcirC27hMIbeE3iLRSAk359hcAx9qExRKkAKM0CiErNBxT8s440wTDr8xiUw8-Qdxi7PrjACD8PTqlwEU0jRvhg3iwxbRU0QaJp_w5rvMAoi6AZELeAT3s6fS |
| ContentType | Journal Article |
| Copyright | American Association for Laboratory Animal Science 2008 |
| Copyright_xml | – notice: American Association for Laboratory Animal Science 2008 |
| DBID | FBQ CGR CUY CVF ECM EIF NPM 7S9 L.6 7X8 5PM |
| DatabaseName | AGRIS Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed AGRICOLA AGRICOLA - Academic MEDLINE - Academic PubMed Central (Full Participant titles) |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) AGRICOLA AGRICOLA - Academic MEDLINE - Academic |
| DatabaseTitleList | MEDLINE AGRICOLA MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: FBQ name: AGRIS url: http://www.fao.org/agris/Centre.asp?Menu_1ID=DB&Menu_2ID=DB1&Language=EN&Content=http://www.fao.org/agris/search?Language=EN sourceTypes: Publisher |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Agriculture |
| EndPage | 340 |
| ExternalDocumentID | PMC2706043 18724774 aalas/cm/2008/00000058/00000004/art00001 US201301560110 |
| Genre | Journal Article Review |
| GroupedDBID | --- .GJ 29F 2WC 53G 5GY 6P2 AAKDD ACCCW ADBBV AENEX AI. ALMA_UNASSIGNED_HOLDINGS BAWUL DIK E3Z EBS EJD F5P FBQ FIJ HDH HYE IPNFZ OK1 RIG RPM SJN VH1 XOL ZXP ~KM CGR CUY CVF ECM EIF NPM 7S9 L.6 7X8 5PM |
| ID | FETCH-LOGICAL-f448t-7417231ddb2a841d0ee4c8ecb6b2d89bb61de1dd25ae91d72a90cbeb07cce1873 |
| IEDL.DBID | FIJ |
| ISSN | 1532-0820 |
| IngestDate | Thu Aug 21 18:19:35 EDT 2025 Fri Jul 11 12:41:36 EDT 2025 Fri Jul 11 03:16:19 EDT 2025 Sat Sep 28 07:50:28 EDT 2024 Thu Jan 27 13:08:27 EST 2022 Fri Nov 08 06:06:09 EST 2024 Thu Apr 03 09:43:25 EDT 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 4 |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-f448t-7417231ddb2a841d0ee4c8ecb6b2d89bb61de1dd25ae91d72a90cbeb07cce1873 |
| Notes | 1532-0820(20080815)58:4L.324;1- ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 ObjectType-Review-3 |
| PMID | 18724774 |
| PQID | 48128875 |
| PQPubID | 24069 |
| PageCount | 17 |
| ParticipantIDs | proquest_miscellaneous_69461410 ingenta_journals_aalas_cm_2008_00000058_00000004_art00001 pubmedcentral_primary_oai_pubmedcentral_nih_gov_2706043 pubmed_primary_18724774 fao_agris_US201301560110 proquest_miscellaneous_48128875 ingenta_journals_ic_aalas_15320820_v58n4_20210817_1123_default_tar_gz_s1 |
| PublicationCentury | 2000 |
| PublicationDate | 2008-08-01 |
| PublicationDateYYYYMMDD | 2008-08-01 |
| PublicationDate_xml | – month: 08 year: 2008 text: 2008-08-01 day: 01 |
| PublicationDecade | 2000 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States |
| PublicationTitle | Comparative medicine |
| PublicationTitleAbbrev | Comp Med |
| PublicationTitleAlternate | Comp Med |
| PublicationYear | 2008 |
| Publisher | American Association for Laboratory Animal Science |
| Publisher_xml | – name: American Association for Laboratory Animal Science |
| References | 7697740 - Cell Immunol. 1995 Apr 1;161(2):288-94 2370110 - Infect Immun. 1990 Aug;58(8):2599-605 16216527 - Protein Expr Purif. 2006 Mar;46(1):64-72 448196 - J Infect Dis. 1979 Jun;139(6):707-11 6118761 - Lancet. 1981 Dec 19-26;2(8260-61):1389-90 16899409 - Tuberculosis (Edinb). 2007 Mar;87(2):87-93 6983888 - Br J Exp Pathol. 1982 Aug;63(4):362-8 7729449 - Eur J Clin Microbiol Infect Dis. 1995 Jan;14(1):25-33 11523029 - J Biomed Mater Res. 2001 Dec 5;57(3):346-56 7891566 - Mol Microbiol. 1994 Nov;14(4):809-22 6342707 - Br J Vener Dis. 1983 Jun;59(3):157-68 6816772 - J Am Vet Med Assoc. 1982 Nov 15;181(10):1030-6 8641758 - Infect Immun. 1996 Mar;64(3):1048-50 8730560 - Br J Hosp Med. 1996 Apr 3-16;55(7):388-93 2418114 - J Immunol. 1986 Feb 15;136(4):1406-14 6355294 - J Immunol. 1983 Nov;131(5):2420-6 15897280 - J Exp Med. 2005 May 16;201(10):1669-76 6989445 - Br J Vener Dis. 1980 Feb;56(1):20-5 6205058 - J Hosp Infect. 1984 Jun;5(2):181-8 10025978 - Cytokine. 1998 Nov;10(11):851-9 15687022 - Tuberculosis (Edinb). 2005 Jan-Mar;85(1-2):13-7 3286521 - Int Arch Allergy Appl Immunol. 1988;86(1):76-81 15731082 - Infect Immun. 2005 Mar;73(3):1811-9 4991996 - Am Rev Respir Dis. 1970 Dec;102(6):937-49 3527250 - Br J Exp Pathol. 1986 Aug;67(4):527-36 3102949 - Mol Immunol. 1986 Nov;23(11):1149-56 5009706 - J Exp Med. 1972 Jan;135(1):98-109 1398989 - Infect Immun. 1992 Nov;60(11):4781-92 5559611 - J Exp Med. 1971 Aug 1;134(2):471-81 83526 - Microbiol Immunol. 1978;22(9):545-55 15731034 - Infect Immun. 2005 Mar;73(3):1367-76 6469355 - Infect Immun. 1984 Sep;45(3):685-91 14112274 - J Exp Med. 1963 Dec 1;118:953-7 2010636 - J Infect Dis. 1991 Apr;163(4):830-6 2807531 - Infect Immun. 1989 Nov;57(11):3458-65 4818461 - J Immunol. 1974 May;112(5):1845-54 7292213 - Sex Transm Dis. 1981 Jul-Sep;8(3):203-10 8109949 - Antimicrob Agents Chemother. 1993 Dec;37(12):2754-5 9290532 - Am Surg. 1997 Sep;63(9):831-5 15451613 - Vet Immunol Immunopathol. 2004 Nov;102(1-2):33-44 15469430 - Cell Microbiol. 2004 Nov;6(11):1011-8 86314 - Ann Intern Med. 1979 Apr;90(4):634-8 16368975 - Infect Immun. 2006 Jan;74(1):213-24 8791713 - Curr Top Microbiol Immunol. 1996;215:157-79 11442841 - Mol Microbiol. 2001 Jun;40(6):1439-47 15897626 - Exp Anim. 2005 Apr;54(2):163-72 2668197 - Int Arch Allergy Appl Immunol. 1989;89(2-3):128-35 11854207 - Infect Immun. 2002 Mar;70(3):1245-53 8173076 - DNA Seq. 1993;4(2):123-8 7365275 - J Infect Dis. 1980 Feb;141(2):186-92 17695979 - RN. 2007 Jul;70(7):26-31; quiz 32 6631074 - J Infect Dis. 1983 Nov;148(5):823-35 6601569 - Chest. 1983 May;83(5 Suppl):15S-16S 713539 - J Surg Res. 1978 Nov;25(5):394-403 2457553 - Infect Immun. 1988 Sep;56(9):2243-9 12540568 - Infect Immun. 2003 Feb;71(2):864-71 9736583 - Antimicrob Agents Chemother. 1998 Sep;42(9):2449-51 11055767 - Int J Tuberc Lung Dis. 2000 Oct;4(10):980-7 3623706 - Infect Immun. 1987 Sep;55(9):2317-9 2052090 - Nature. 1991 Jun 20;351(6328):649-52 11526093 - Int Immunol. 2001 Sep;13(9):1129-39 9225917 - Surgery. 1997 Jul;122(1):69-72 3525408 - Infect Immun. 1986 Aug;53(2):305-11 2523350 - Infect Immun. 1989 May;57(5):1374-9 12496185 - Infect Immun. 2003 Jan;71(1):354-64 9626335 - Cell Immunol. 1998 Feb 25;184(1):51-7 4989151 - Science. 1970 Oct 2;170(3953):74-5 989469 - Br J Vener Dis. 1976 Aug;52(4):257-60 10036727 - Trends Microbiol. 1998 Dec;6(12):484-8 8749675 - Clin Infect Dis. 1995 Dec;21 Suppl 3:S265-76 434656 - Ann Intern Med. 1979 Apr;90(4):690 1427970 - Immunology. 1992 Oct;77(2):165-70 8613484 - J Clin Immunol. 1995 Nov;15(6 Suppl):113S-121S 6062006 - J Exp Med. 1967 Nov 1;126(5):959-67 2014980 - Antimicrob Agents Chemother. 1991 Jan;35(1):5-9 6983846 - Am Rev Respir Dis. 1982 Dec;126(6):1050-7 17079089 - Burns. 2007 Feb;33(1):52-8 3816932 - Eur J Immunol. 1986 Dec;16(12):1515-9 9080667 - Comp Biochem Physiol B Biochem Mol Biol. 1997 Jan;116(1):99-107 2931380 - Infect Immun. 1985 Oct;50(1):66-72 15684799 - Surg Infect (Larchmt). 2004 Fall;5(3):281-8 2203824 - J Clin Invest. 1990 Sep;86(3):817-24 6724697 - Infect Immun. 1984 Jun;44(3):753-5 1910107 - JPEN J Parenter Enteral Nutr. 1991 Jul-Aug;15(4):433-6 3533780 - Infect Immun. 1986 Nov;54(2):456-64 3719461 - Can J Microbiol. 1986 May;32(5):438-42 3295048 - J Immunol. 1987 Jun 15;138(12):4435-40 1347317 - J Nutr. 1992 Mar;122(3 Suppl):738-43 7737435 - Fundam Appl Toxicol. 1995 Feb;24(2):238-46 7726534 - Antimicrob Agents Chemother. 1995 Feb;39(2):559-60 3884485 - Genitourin Med. 1985 Apr;61(2):75-81 6607210 - Immunology. 1984 Feb;51(2):275-85 397933 - Infect Immun. 1979 Nov;26(2):728-35 9673234 - Infect Immun. 1998 Aug;66(8):3562-8 12491233 - Semin Pediatr Infect Dis. 2002 Oct;13(4):273-9 9653083 - J Exp Med. 1998 Jul 6;188(1):49-60 3974117 - JAMA. 1985 Apr 19;253(15):2246-50 2977131 - J Biochem. 1988 Sep;104(3):383-7 7985998 - Antimicrob Agents Chemother. 1994 Aug;38(8):1703-10 11179349 - Infect Immun. 2001 Mar;69(3):1722-8 11146007 - Am J Emerg Med. 2001 Jan;19(1):1-5 2909492 - Infect Immun. 1989 Jan;57(1):299-301 3910539 - Genitourin Med. 1985 Feb;61(1):21-6 7141709 - Infect Immun. 1982 Nov;38(2):699-705 11239788 - Trends Microbiol. 2001 Mar;9(3):115-8 16299346 - Infect Immun. 2005 Dec;73(12):8437-41 67168 - J Exp Med. 1977 Apr 1;145(4):1093-8 3546103 - Immunology. 1987 Feb;60(2):281-5 16428800 - Infect Immun. 2006 Feb;74(2):1436-41 16139397 - Vaccine. 2006 Jan 9;24(1):2-19 6158543 - J Exp Med. 1980 Oct 1;152(4):1011-23 6197362 - Immunology. 1984 Jan;51(1):93-102 74389 - J Immunol. 1978 Feb;120(2):438-44 7014622 - J Clin Microbiol. 1981 Apr;13(4):726-9 8335528 - J Antimicrob Chemother. 1993 May;31 Suppl D:97-102 11286786 - Trends Mol Med. 2001 Mar;7(3):135-7 10645450 - Tuber Lung Dis. 1998;79(2):119-26 12438333 - Infect Immun. 2002 Dec;70(12):6614-20 1829503 - Mol Immunol. 1991 Apr-May;28(4-5):375-82 2960561 - FEBS Lett. 1987 Nov 16;224(1):29-32 5271167 - Proc Natl Acad Sci U S A. 1970 Jun;66(2):322-8 16710801 - J Mol Histol. 2006 Jan;37(1-2):15-25 12360067 - Plast Reconstr Surg. 2002 Oct;110(5):1275-9 8637593 - Nature. 1996 Jun 13;381(6583):597-600 9517930 - Antimicrob Agents Chemother. 1998 Mar;42(3):545-9 6345589 - J Clin Invest. 1983 Jun;71(6):1686-97 6603421 - Infect Immun. 1983 Aug;41(2):876-9 9824482 - Immunology. 1998 Oct;95(2):242-7 3874819 - Immunology. 1985 Jul;55(3):519-30 1937794 - Infect Immun. 1991 Dec;59(12):4343-8 3903975 - Scand J Infect Dis. 1985;17(3):303-10 2137114 - Infect Immun. 1990 Feb;58(2):563-5 52675 - J Immunol. 1975 Dec;115(6):1704-10 7751659 - J Infect. 1995 Jan;30(1):13-6 7141707 - Infect Immun. 1982 Nov;38(2):620-2 6501409 - J Cell Biol. 1984 Dec;99(6):1936-43 11683246 - Pharm Res. 2001 Sep;18(9):1315-9 16971416 - J Antimicrob Chemother. 2006 Nov;58(5):980-6 7018625 - Blut. 1981 Jun;42(6):379-82 3610314 - Infect Immun. 1987 Aug;55(8):1767-73 7591122 - Infect Immun. 1995 Dec;63(12):4675-81 8031472 - Pathobiology. 1994;62(1):14-28 5559610 - J Exp Med. 1971 Aug 1;134(2):458-70 16296870 - Drugs. 2005;65(17):2437-44 9537756 - FEMS Immunol Med Microbiol. 1997 Dec;19(4):307-14 14573630 - Infect Immun. 2003 Nov;71(11):6148-54 15755579 - Vaccine. 2005 Mar 18;23(17-18):2105-8 10393970 - Proc Natl Acad Sci U S A. 1999 Jul 6;96(14):8190-5 4035522 - Sex Transm Dis. 1985 Jul-Sep;12(3):155-8 7252150 - J Immunol. 1981 Aug;127(2):608-12 963491 - Br J Vener Dis. 1976 Aug;52(4):261-5 2958691 - Mol Immunol. 1987 Aug;24(8):831-7 15139466 - Int J Tuberc Lung Dis. 2004 Mar;8(3):286-98 6644240 - J Exp Med. 1983 Dec 1;158(6):2108-26 6323536 - J Clin Invest. 1984 Apr;73(4):1191-200 7144138 - Lab Invest. 1982 Dec;47(6):568-78 2547250 - Sex Transm Dis. 1989 Jan-Mar;16(1):41-6 3744550 - Infect Immun. 1986 Sep;53(3):553-9 10816466 - Infect Immun. 2000 Jun;68(6):3219-25 8476453 - Am J Emerg Med. 1993 Mar;11(2):134-8 2670347 - Clin Exp Immunol. 1989 Jul;77(1):144-50 3276631 - Int Arch Allergy Appl Immunol. 1988;85(2):252-6 7709325 - Sex Transm Dis. 1995 Jan-Feb;22(1):48-54 16418521 - Clin Microbiol Rev. 2006 Jan;19(1):29-49 8907586 - Inflamm Res. 1996 Feb;45(2):62-7 2668194 - Infect Immun. 1989 Sep;57(9):2900-2 6339080 - Cell Immunol. 1983 Feb 15;76(1):129-36 2580546 - Br J Exp Pathol. 1985 Apr;66(2):173-83 15297705 - Exp Anim. 2004 Jul;53(4):321-9 88533 - Jpn J Med Sci Biol. 1978 Oct-Dec;31(5-6):425-30 10358761 - Annu Rev Immunol. 1999;17:297-329 14977928 - Infect Immun. 2004 Mar;72(3):1275-83 2975973 - Clin Exp Immunol. 1988 Nov;74(2):171-6 10219257 - Clin Immunol. 1999 Apr;91(1):77-83 776839 - Int Arch Allergy Appl Immunol. 1976;51(3):284-97 2525616 - J Pediatr Surg. 1989 Jun;24(6):519-21 5655655 - Proc Soc Exp Biol Med. 1968 Apr;127(4):1139-41 335245 - N Engl J Med. 1977 Dec 1;297(22):1197-203 12628549 - FEMS Immunol Med Microbiol. 2003 Mar 20;35(2):135-40 12228272 - Infect Immun. 2002 Oct;70(10):5471-8 12047745 - Immunology. 2002 Jun;106(2):159-72 2926324 - J Exp Med. 1989 Mar 1;169(3):691-705 8092833 - Antimicrob Agents Chemother. 1994 Jun;38(6):1325-30 640729 - Infect Immun. 1978 Mar;19(3):807-13 7486895 - Antimicrob Agents Chemother. 1995 Aug;39(8):1655-60 4031129 - J Comp Pathol. 1985 Jul;95(3):335-44 14594847 - J Bacteriol. 2003 Nov;185(22):6712-8 6822430 - Infect Immun. 1983 Jan;39(1):463-5 16710326 - Nat Rev Microbiol. 2006 Jun;4(6):469-76 3610378 - Int J Biomed Comput. 1987 Jul;21(1):67-74 16291674 - J Bacteriol. 2005 Dec;187(23):8006-19 9257769 - Antimicrob Agents Chemother. 1997 Aug;41(8):1815-7 3543209 - J Gen Microbiol. 1986 Jun;132(6):1565-74 3805776 - J Infect Dis. 1987 Mar;155(3):524-31 7150500 - Br J Exp Pathol. 1982 Aug;63(4):355-61 14705990 - Tissue Antigens. 2004 Feb;63(2):184-9 7682999 - Infect Immun. 1993 May;61(5):1972-9 3819647 - J Exp Med. 1987 Mar 1;165(3):799-811 7190579 - J Clin Invest. 1980 Sep;66(3):441-50 6351091 - Proc Soc Exp Biol Med. 1983 Sep;173(4):547-52 7216476 - Infect Immun. 1981 Feb;31(2):822-4 7913699 - Infect Immun. 1994 Aug;62(8):3454-62 2967427 - Mol Immunol. 1988 Feb;25(2):205-11 3932191 - Immunology. 1985 Oct;56(2):195-202 7799832 - Microbiol Immunol. 1994;38(8):599-605 14742563 - Infect Immun. 2004 Feb;72(2):1147-9 1999485 - J Clin Invest. 1991 Mar;87(3):1054-9 2322389 - Burns. 1990 Feb;16(1):13-6 8432872 - J Clin Invest. 1993 Feb;91(2):717-23 8300238 - Inf |
| References_xml | – reference: 3881539 - J Infect Dis. 1985 Feb;151(2):264-72 – reference: 15731082 - Infect Immun. 2005 Mar;73(3):1811-9 – reference: 3458697 - J Antimicrob Chemother. 1986 Apr;17 Suppl B:41-8 – reference: 9080667 - Comp Biochem Physiol B Biochem Mol Biol. 1997 Jan;116(1):99-107 – reference: 989469 - Br J Vener Dis. 1976 Aug;52(4):257-60 – reference: 16291674 - J Bacteriol. 2005 Dec;187(23):8006-19 – reference: 8798224 - Nutrition. 1996 Mar;12(3):195-9 – reference: 83526 - Microbiol Immunol. 1978;22(9):545-55 – reference: 4035522 - Sex Transm Dis. 1985 Jul-Sep;12(3):155-8 – reference: 2010636 - J Infect Dis. 1991 Apr;163(4):830-6 – reference: 1829503 - Mol Immunol. 1991 Apr-May;28(4-5):375-82 – reference: 5126638 - J Exp Med. 1971 Dec 1;134(6):1529-37 – reference: 430546 - J Med Microbiol. 1979 Feb;12(1):55-62 – reference: 8603533 - Clin Exp Immunol. 1996 Apr;104(1):48-53 – reference: 3276631 - Int Arch Allergy Appl Immunol. 1988;85(2):252-6 – reference: 8031472 - Pathobiology. 1994;62(1):14-28 – reference: 8641758 - Infect Immun. 1996 Mar;64(3):1048-50 – reference: 15755579 - Vaccine. 2005 Mar 18;23(17-18):2105-8 – reference: 5273452 - Proc Natl Acad Sci U S A. 1970 Aug;66(4):1267-74 – reference: 8613484 - J Clin Immunol. 1995 Nov;15(6 Suppl):113S-121S – reference: 6693135 - Immunology. 1984 Feb;51(2):287-94 – reference: 7252150 - J Immunol. 1981 Aug;127(2):608-12 – reference: 6983888 - Br J Exp Pathol. 1982 Aug;63(4):362-8 – reference: 2580546 - Br J Exp Pathol. 1985 Apr;66(2):173-83 – reference: 16730231 - Tuberculosis (Edinb). 2006 Nov;86(6):419-29 – reference: 12047745 - Immunology. 2002 Jun;106(2):159-72 – reference: 2547250 - Sex Transm Dis. 1989 Jan-Mar;16(1):41-6 – reference: 67168 - J Exp Med. 1977 Apr 1;145(4):1093-8 – reference: 8168978 - Infect Immun. 1994 May;62(5):2111-4 – reference: 4594119 - Infect Immun. 1973 Dec;8(6):925-30 – reference: 10393970 - Proc Natl Acad Sci U S A. 1999 Jul 6;96(14):8190-5 – reference: 15897280 - J Exp Med. 2005 May 16;201(10):1669-76 – reference: 7050146 - J Clin Microbiol. 1982 Jun;15(6):1092-6 – reference: 6205058 - J Hosp Infect. 1984 Jun;5(2):181-8 – reference: 7504015 - J Immunol. 1993 Dec 1;151(11):6225-36 – reference: 14505796 - Biochem Pharmacol. 2003 Oct 1;66(7):1171-80 – reference: 8644997 - Arch Biochem Biophys. 1996 Apr 15;328(2):219-26 – reference: 635520 - Sci Am. 1978 Jan;238(1):86-95 – reference: 74389 - J Immunol. 1978 Feb;120(2):438-44 – reference: 4991996 - Am Rev Respir Dis. 1970 Dec;102(6):937-49 – reference: 7913699 - Infect Immun. 1994 Aug;62(8):3454-62 – reference: 3934130 - J Antimicrob Chemother. 1985 Oct;16(4):519-26 – reference: 9290532 - Am Surg. 1997 Sep;63(9):831-5 – reference: 11447151 - Infect Immun. 2001 Aug;69(8):4782-9 – reference: 3932191 - Immunology. 1985 Oct;56(2):195-202 – reference: 17695979 - RN. 2007 Jul;70(7):26-31; quiz 32 – reference: 2670347 - Clin Exp Immunol. 1989 Jul;77(1):144-50 – reference: 10645450 - Tuber Lung Dis. 1998;79(2):119-26 – reference: 10948157 - Infect Immun. 2000 Sep;68(9):5293-8 – reference: 15469430 - Cell Microbiol. 2004 Nov;6(11):1011-8 – reference: 9709046 - N Engl J Med. 1998 Aug 20;339(8):520-32 – reference: 6724697 - Infect Immun. 1984 Jun;44(3):753-5 – reference: 86314 - Ann Intern Med. 1979 Apr;90(4):634-8 – reference: 7018625 - Blut. 1981 Jun;42(6):379-82 – reference: 3744550 - Infect Immun. 1986 Sep;53(3):553-9 – reference: 7729449 - Eur J Clin Microbiol Infect Dis. 1995 Jan;14(1):25-33 – reference: 16139397 - Vaccine. 2006 Jan 9;24(1):2-19 – reference: 52675 - J Immunol. 1975 Dec;115(6):1704-10 – reference: 6822430 - Infect Immun. 1983 Jan;39(1):463-5 – reference: 8749675 - Clin Infect Dis. 1995 Dec;21 Suppl 3:S265-76 – reference: 9605998 - Clin Diagn Lab Immunol. 1998 May;5(3):401-3 – reference: 88533 - Jpn J Med Sci Biol. 1978 Oct-Dec;31(5-6):425-30 – reference: 7682999 - Infect Immun. 1993 May;61(5):1972-9 – reference: 3102949 - Mol Immunol. 1986 Nov;23(11):1149-56 – reference: 15731034 - Infect Immun. 2005 Mar;73(3):1367-76 – reference: 6501409 - J Cell Biol. 1984 Dec;99(6):1936-43 – reference: 14977939 - Infect Immun. 2004 Mar;72(3):1358-63 – reference: 6158543 - J Exp Med. 1980 Oct 1;152(4):1011-23 – reference: 17406316 - Nat Protoc. 2006;1(2):840-7 – reference: 3715981 - Tubercle. 1986 Mar;67(1):31-9 – reference: 2322389 - Burns. 1990 Feb;16(1):13-6 – reference: 16710326 - Nat Rev Microbiol. 2006 Jun;4(6):469-76 – reference: 9653083 - J Exp Med. 1998 Jul 6;188(1):49-60 – reference: 3623706 - Infect Immun. 1987 Sep;55(9):2317-9 – reference: 2457553 - Infect Immun. 1988 Sep;56(9):2243-9 – reference: 12496185 - Infect Immun. 2003 Jan;71(1):354-64 – reference: 11286786 - Trends Mol Med. 2001 Mar;7(3):135-7 – reference: 7868250 - Infect Immun. 1995 Mar;63(3):804-10 – reference: 10907908 - Sex Transm Dis. 2000 Jul;27(6):329-37 – reference: 16953800 - Cell Microbiol. 2007 Feb;9(2):450-62 – reference: 7891566 - Mol Microbiol. 1994 Nov;14(4):809-22 – reference: 7014622 - J Clin Microbiol. 1981 Apr;13(4):726-9 – reference: 3485568 - Immunology. 1986 Apr;57(4):533-8 – reference: 2538514 - J Immunol Methods. 1989 Mar 31;118(2):193-8 – reference: 5559610 - J Exp Med. 1971 Aug 1;134(2):458-70 – reference: 6607210 - Immunology. 1984 Feb;51(2):275-85 – reference: 11275555 - J Biochem. 2001 Apr;129(4):561-8 – reference: 1900810 - Infect Immun. 1991 Apr;59(4):1346-51 – reference: 12491233 - Semin Pediatr Infect Dis. 2002 Oct;13(4):273-9 – reference: 335245 - N Engl J Med. 1977 Dec 1;297(22):1197-203 – reference: 713539 - J Surg Res. 1978 Nov;25(5):394-403 – reference: 1729190 - Infect Immun. 1992 Jan;60(1):271-7 – reference: 1999485 - J Clin Invest. 1991 Mar;87(3):1054-9 – reference: 6350180 - Infect Immun. 1983 Sep;41(3):1132-7 – reference: 448196 - J Infect Dis. 1979 Jun;139(6):707-11 – reference: 3610378 - Int J Biomed Comput. 1987 Jul;21(1):67-74 – reference: 11179349 - Infect Immun. 2001 Mar;69(3):1722-8 – reference: 963491 - Br J Vener Dis. 1976 Aug;52(4):261-5 – reference: 7709325 - Sex Transm Dis. 1995 Jan-Feb;22(1):48-54 – reference: 1634811 - J Infect Dis. 1992 Aug;166(2):393-9 – reference: 5655655 - Proc Soc Exp Biol Med. 1968 Apr;127(4):1139-41 – reference: 15377675 - J Leukoc Biol. 2004 Dec;76(6):1229-39 – reference: 9673234 - Infect Immun. 1998 Aug;66(8):3562-8 – reference: 3543209 - J Gen Microbiol. 1986 Jun;132(6):1565-74 – reference: 15958260 - Tuberculosis (Edinb). 2005 Jul;85(4):245-58 – reference: 9736583 - Antimicrob Agents Chemother. 1998 Sep;42(9):2449-51 – reference: 7365275 - J Infect Dis. 1980 Feb;141(2):186-92 – reference: 3308709 - Infect Immun. 1987 Oct;55(10):2502-8 – reference: 9257769 - Antimicrob Agents Chemother. 1997 Aug;41(8):1815-7 – reference: 9537756 - FEMS Immunol Med Microbiol. 1997 Dec;19(4):307-14 – reference: 6816772 - J Am Vet Med Assoc. 1982 Nov 15;181(10):1030-6 – reference: 17168911 - Wound Repair Regen. 1994 Jan;2(1):48-56 – reference: 15297705 - Exp Anim. 2004 Jul;53(4):321-9 – reference: 3819647 - J Exp Med. 1987 Mar 1;165(3):799-811 – reference: 12184917 - J Interferon Cytokine Res. 2002 Jul;22(7):793-7 – reference: 14594847 - J Bacteriol. 2003 Nov;185(22):6712-8 – reference: 15687022 - Tuberculosis (Edinb). 2005 Jan-Mar;85(1-2):13-7 – reference: 2523350 - Infect Immun. 1989 May;57(5):1374-9 – reference: 1452353 - Infect Immun. 1992 Dec;60(12):5212-8 – reference: 10948158 - Infect Immun. 2000 Sep;68(9):5299-305 – reference: 6411814 - J Immunol. 1983 Sep;131(3):1350-5 – reference: 3903975 - Scand J Infect Dis. 1985;17(3):303-10 – reference: 1910107 - JPEN J Parenter Enteral Nutr. 1991 Jul-Aug;15(4):433-6 – reference: 397933 - Infect Immun. 1979 Nov;26(2):728-35 – reference: 7799832 - Microbiol Immunol. 1994;38(8):599-605 – reference: 2909492 - Infect Immun. 1989 Jan;57(1):299-301 – reference: 10219257 - Clin Immunol. 1999 Apr;91(1):77-83 – reference: 1427970 - Immunology. 1992 Oct;77(2):165-70 – reference: 9192763 - Blood. 1997 Jun 15;89(12):4393-401 – reference: 11854207 - Infect Immun. 2002 Mar;70(3):1245-53 – reference: 8515103 - J Infect Dis. 1993 Jul;168(1):152-7 – reference: 3884485 - Genitourin Med. 1985 Apr;61(2):75-81 – reference: 16216527 - Protein Expr Purif. 2006 Mar;46(1):64-72 – reference: 7737435 - Fundam Appl Toxicol. 1995 Feb;24(2):238-46 – reference: 4002092 - Sex Transm Dis. 1985 Jan-Mar;12(1):8-13 – reference: 15036239 - Cytokine. 2004 Mar 21;25(6):246-53 – reference: 3666960 - Infect Immun. 1987 Nov;55(11):2701-5 – reference: 3782828 - J Immunol Methods. 1986 Dec 4;95(1):99-105 – reference: 3610314 - Infect Immun. 1987 Aug;55(8):1767-73 – reference: 3816932 - Eur J Immunol. 1986 Dec;16(12):1515-9 – reference: 8092833 - Antimicrob Agents Chemother. 1994 Jun;38(6):1325-30 – reference: 434656 - Ann Intern Med. 1979 Apr;90(4):690 – reference: 12704109 - Infect Immun. 2003 May;71(5):2394-403 – reference: 11533012 - J Antimicrob Chemother. 2001 Sep;48(3):431-4 – reference: 16428800 - Infect Immun. 2006 Feb;74(2):1436-41 – reference: 6935294 - J Immunol. 1981 Jan;126(1):32-7 – reference: 15207803 - Tuberculosis (Edinb). 2004;84(5):283-92 – reference: 9225917 - Surgery. 1997 Jul;122(1):69-72 – reference: 3805776 - J Infect Dis. 1987 Mar;155(3):524-31 – reference: 16971416 - J Antimicrob Chemother. 2006 Nov;58(5):980-6 – reference: 3910539 - Genitourin Med. 1985 Feb;61(1):21-6 – reference: 4344096 - Infect Immun. 1972 Jun;5(6):921-6 – reference: 16418521 - Clin Microbiol Rev. 2006 Jan;19(1):29-49 – reference: 5009706 - J Exp Med. 1972 Jan;135(1):98-109 – reference: 1971259 - Infect Immun. 1990 Jun;58(6):1843-7 – reference: 3510176 - Infect Immun. 1986 Jan;51(1):365-8 – reference: 8052122 - Mol Microbiol. 1994 Jun;12(5):693-705 – reference: 4818461 - J Immunol. 1974 May;112(5):1845-54 – reference: 6355294 - J Immunol. 1983 Nov;131(5):2420-6 – reference: 3897379 - J Immunol. 1985 Oct;135(4):2829-34 – reference: 7141709 - Infect Immun. 1982 Nov;38(2):699-705 – reference: 8173076 - DNA Seq. 1993;4(2):123-8 – reference: 776839 - Int Arch Allergy Appl Immunol. 1976;51(3):284-97 – reference: 8539085 - Pathol Biol (Paris). 1995 Jun;43(6):569-72 – reference: 6601569 - Chest. 1983 May;83(5 Suppl):15S-16S – reference: 3227473 - Sex Transm Dis. 1988 Jul-Sep;15(3):169-73 – reference: 2525616 - J Pediatr Surg. 1989 Jun;24(6):519-21 – reference: 2975973 - Clin Exp Immunol. 1988 Nov;74(2):171-6 – reference: 4881246 - J Surg Res. 1968 Dec;8(12):585-92 – reference: 3308224 - Clin Exp Immunol. 1987 Aug;69(2):263-70 – reference: 7985998 - Antimicrob Agents Chemother. 1994 Aug;38(8):1703-10 – reference: 4989151 - Science. 1970 Oct 2;170(3953):74-5 – reference: 8564359 - Trends Microbiol. 1995 Oct;3(10):397-401 – reference: 12228272 - Infect Immun. 2002 Oct;70(10):5471-8 – reference: 2644069 - Crit Rev Microbiol. 1989;16(3):181-234 – reference: 14977928 - Infect Immun. 2004 Mar;72(3):1275-83 – reference: 7625801 - Antimicrob Agents Chemother. 1995 May;39(5):1134-9 – reference: 1452498 - J Antimicrob Chemother. 1992 Sep;30(3):327-37 – reference: 2668197 - Int Arch Allergy Appl Immunol. 1989;89(2-3):128-35 – reference: 9824482 - Immunology. 1998 Oct;95(2):242-7 – reference: 6342707 - Br J Vener Dis. 1983 Jun;59(3):157-68 – reference: 8875923 - N Engl J Med. 1996 Nov 7;335(19):1445-53 – reference: 7634350 - Cell Immunol. 1995 Aug;164(1):28-35 – reference: 9488377 - Infect Immun. 1998 Mar;66(3):927-31 – reference: 7216476 - Infect Immun. 1981 Feb;31(2):822-4 – reference: 6469355 - Infect Immun. 1984 Sep;45(3):685-91 – reference: 9626335 - Cell Immunol. 1998 Feb 25;184(1):51-7 – reference: 15684799 - Surg Infect (Larchmt). 2004 Fall;5(3):281-8 – reference: 6631074 - J Infect Dis. 1983 Nov;148(5):823-35 – reference: 6339080 - Cell Immunol. 1983 Feb 15;76(1):129-36 – reference: 10816466 - Infect Immun. 2000 Jun;68(6):3219-25 – reference: 6603421 - Infect Immun. 1983 Aug;41(2):876-9 – reference: 6491367 - J Infect Dis. 1984 Oct;150(4):546-53 – reference: 12628549 - FEMS Immunol Med Microbiol. 2003 Mar 20;35(2):135-40 – reference: 830742 - J Immunol. 1977 Jan;118(1):103-8 – reference: 12360067 - Plast Reconstr Surg. 2002 Oct;110(5):1275-9 – reference: 12818162 - Immunity. 2003 Jun;18(6):813-23 – reference: 17079089 - Burns. 2007 Feb;33(1):52-8 – reference: 6644240 - J Exp Med. 1983 Dec 1;158(6):2108-26 – reference: 4837103 - Monogr Allergy. 1974;8(0):83-8 – reference: 1347317 - J Nutr. 1992 Mar;122(3 Suppl):738-43 – reference: 13704282 - J Exp Med. 1961 Mar 1;113:571-85 – reference: 2052090 - Nature. 1991 Jun 20;351(6328):649-52 – reference: 8919742 - Sex Transm Dis. 1996 Mar-Apr;23(2):145-50 – reference: 12010960 - Infect Immun. 2002 Jun;70(6):2758-62 – reference: 1398746 - Immunology. 1992 Aug;76(4):548-52 – reference: 15139466 - Int J Tuberc Lung Dis. 2004 Mar;8(3):286-98 – reference: 2203824 - J Clin Invest. 1990 Sep;86(3):817-24 – reference: 1639492 - Infect Immun. 1992 Aug;60(8):3217-23 – reference: 11228367 - Vaccine. 2001 Feb 28;19(15-16):1968-77 – reference: 3295048 - J Immunol. 1987 Jun 15;138(12):4435-40 – reference: 1937794 - Infect Immun. 1991 Dec;59(12):4343-8 – reference: 17213696 - J Vet Med Sci. 2006 Dec;68(12):1281-7 – reference: 6197362 - Immunology. 1984 Jan;51(1):93-102 – reference: 7751659 - J Infect. 1995 Jan;30(1):13-6 – reference: 7141707 - Infect Immun. 1982 Nov;38(2):620-2 – reference: 7486895 - Antimicrob Agents Chemother. 1995 Aug;39(8):1655-60 – reference: 11239788 - Trends Microbiol. 2001 Mar;9(3):115-8 – reference: 3874819 - Immunology. 1985 Jul;55(3):519-30 – reference: 14705990 - Tissue Antigens. 2004 Feb;63(2):184-9 – reference: 5043524 - N Engl J Med. 1972 Aug 24;287(8):388-97 – reference: 7036941 - Arch Pathol Lab Med. 1982 Mar;106(3):105-7 – reference: 7144138 - Lab Invest. 1982 Dec;47(6):568-78 – reference: 14742563 - Infect Immun. 2004 Feb;72(2):1147-9 – reference: 3974117 - JAMA. 1985 Apr 19;253(15):2246-50 – reference: 8791713 - Curr Top Microbiol Immunol. 1996;215:157-79 – reference: 14573630 - Infect Immun. 2003 Nov;71(11):6148-54 – reference: 2977131 - J Biochem. 1988 Sep;104(3):383-7 – reference: 11055767 - Int J Tuberc Lung Dis. 2000 Oct;4(10):980-7 – reference: 937230 - Am J Clin Nutr. 1976 Jul;29(7):762-5 – reference: 8494364 - Antimicrob Agents Chemother. 1993 Apr;37(4):702-7 – reference: 6345589 - J Clin Invest. 1983 Jun;71(6):1686-97 – reference: 5559611 - J Exp Med. 1971 Aug 1;134(2):471-81 – reference: 8246847 - Microbiol Rev. 1993 Sep;57(3):750-79 – reference: 16296870 - Drugs. 2005;65(17):2437-44 – reference: 11959588 - Antimicrob Agents Chemother. 2002 May;46(5):1503-9 – reference: 7510322 - J Gen Microbiol. 1993 Dec;139(12):2965-72 – reference: 12077262 - J Immunol. 2002 Jul 1;169(1):330-9 – reference: 10553074 - J Immunol. 1999 Nov 15;163(10):5478-88 – reference: 8730560 - Br J Hosp Med. 1996 Apr 3-16;55(7):388-93 – reference: 2807531 - Infect Immun. 1989 Nov;57(11):3458-65 – reference: 17437366 - Surg Infect (Larchmt). 2007 Apr;8(2):209-14 – reference: 8335528 - J Antimicrob Chemother. 1993 May;31 Suppl D:97-102 – reference: 6983846 - Am Rev Respir Dis. 1982 Dec;126(6):1050-7 – reference: 6351091 - Proc Soc Exp Biol Med. 1983 Sep;173(4):547-52 – reference: 16712933 - Mol Immunol. 2007 Feb;44(5):878-88 – reference: 2960561 - FEBS Lett. 1987 Nov 16;224(1):29-32 – reference: 2370110 - Infect Immun. 1990 Aug;58(8):2599-605 – reference: 7591122 - Infect Immun. 1995 Dec;63(12):4675-81 – reference: 3525408 - Infect Immun. 1986 Aug;53(2):305-11 – reference: 11523029 - J Biomed Mater Res. 2001 Dec 5;57(3):346-56 – reference: 3286521 - Int Arch Allergy Appl Immunol. 1988;86(1):76-81 – reference: 2137114 - Infect Immun. 1990 Feb;58(2):563-5 – reference: 7988715 - FEBS Lett. 1994 Dec 12;356(1):33-8 – reference: 2668194 - Infect Immun. 1989 Sep;57(9):2900-2 – reference: 7150500 - Br J Exp Pathol. 1982 Aug;63(4):355-61 – reference: 7726534 - Antimicrob Agents Chemother. 1995 Feb;39(2):559-60 – reference: 3527250 - Br J Exp Pathol. 1986 Aug;67(4):527-36 – reference: 1692213 - Biochem Biophys Res Commun. 1990 Apr 30;168(2):683-9 – reference: 12874302 - Infect Immun. 2003 Aug;71(8):4271-7 – reference: 2109574 - Antimicrob Agents Chemother. 1990 Jan;34(1):21-4 – reference: 10036727 - Trends Microbiol. 1998 Dec;6(12):484-8 – reference: 16473044 - Tuberculosis (Edinb). 2006 Sep;86(5):386-94 – reference: 7119479 - J Infect Dis. 1982 Oct;146(4):487-97 – reference: 7292213 - Sex Transm Dis. 1981 Jul-Sep;8(3):203-10 – reference: 6989445 - Br J Vener Dis. 1980 Feb;56(1):20-5 – reference: 7190579 - J Clin Invest. 1980 Sep;66(3):441-50 – reference: 16710801 - J Mol Histol. 2006 Jan;37(1-2):15-25 – reference: 546788 - Infect Immun. 1979 Nov;26(2):573-9 – reference: 10358761 - Annu Rev Immunol. 1999;17:297-329 – reference: 2418114 - J Immunol. 1986 Feb 15;136(4):1406-14 – reference: 7697740 - Cell Immunol. 1995 Apr 1;161(2):288-94 – reference: 11146007 - Am J Emerg Med. 2001 Jan;19(1):1-5 – reference: 6420578 - J Trauma. 1984 Feb;24(2):106-15 – reference: 2958691 - Mol Immunol. 1987 Aug;24(8):831-7 – reference: 3719461 - Can J Microbiol. 1986 May;32(5):438-42 – reference: 16368975 - Infect Immun. 2006 Jan;74(1):213-24 – reference: 8637593 - Nature. 1996 Jun 13;381(6583):597-600 – reference: 373549 - Ann Intern Med. 1979 Apr;90(4):664-6 – reference: 3065217 - Immunology. 1988 Dec;65(4):523-8 – reference: 8757850 - Infect Immun. 1996 Aug;64(8):3174-9 – reference: 3533780 - Infect Immun. 1986 Nov;54(2):456-64 – reference: 2931380 - Infect Immun. 1985 Oct;50(1):66-72 – reference: 8300238 - Infect Immun. 1994 Feb;62(2):751-3 – reference: 8907586 - Inflamm Res. 1996 Feb;45(2):62-7 – reference: 11544529 - Nature. 2001 Sep 6;413(6851):78-83 – reference: 11294723 - Emerg Infect Dis. 2001 Mar-Apr;7(2):277-81 – reference: 3546103 - Immunology. 1987 Feb;60(2):281-5 – reference: 6118761 - Lancet. 1981 Dec 19-26;2(8260-61):1389-90 – reference: 4628703 - J Immunol. 1972 Dec;109(6):1174-81 – reference: 640729 - Infect Immun. 1978 Mar;19(3):807-13 – reference: 14210490 - Br J Vener Dis. 1964 Sep;40:213-6 – reference: 9233647 - J Immunol. 1997 Aug 1;159(3):1482-9 – reference: 11920318 - J Infect Dis. 2002 Apr 1;185(7):937-43 – reference: 16299346 - Infect Immun. 2005 Dec;73(12):8437-41 – reference: 6323536 - J Clin Invest. 1984 Apr;73(4):1191-200 – reference: 6359491 - Sex Transm Dis. 1983 Jul-Sep;10(3):123-5 – reference: 8109949 - Antimicrob Agents Chemother. 1993 Dec;37(12):2754-5 – reference: 2926324 - J Exp Med. 1989 Mar 1;169(3):691-705 – reference: 14082222 - Nature. 1963 Nov 9;200:544-6 – reference: 16899409 - Tuberculosis (Edinb). 2007 Mar;87(2):87-93 – reference: 11683246 - Pharm Res. 2001 Sep;18(9):1315-9 – reference: 9517930 - Antimicrob Agents Chemother. 1998 Mar;42(3):545-9 – reference: 7235365 - Am Rev Respir Dis. 1981 Feb;123(2):238-9 – reference: 8476453 - Am J Emerg Med. 1993 Mar;11(2):134-8 – reference: 3182448 - J Antimicrob Chemother. 1988 Jul;22 Suppl B:69-72 – reference: 11526093 - Int Immunol. 2001 Sep;13(9):1129-39 – reference: 16533513 - J Immunol Methods. 2006 Apr 20;311(1-2):47-56 – reference: 8432872 - J Clin Invest. 1993 Feb;91(2):717-23 – reference: 2014980 - Antimicrob Agents Chemother. 1991 Jan;35(1):5-9 – reference: 2967427 - Mol Immunol. 1988 Feb;25(2):205-11 – reference: 12540568 - Infect Immun. 2003 Feb;71(2):864-71 – reference: 4031129 - J Comp Pathol. 1985 Jul;95(3):335-44 – reference: 1398989 - Infect Immun. 1992 Nov;60(11):4781-92 – reference: 11442841 - Mol Microbiol. 2001 Jun;40(6):1439-47 – reference: 10025978 - Cytokine. 1998 Nov;10(11):851-9 – reference: 14112274 - J Exp Med. 1963 Dec 1;118:953-7 – reference: 374637 - J Infect Dis. 1979 Jan;139(1):60-8 – reference: 3570468 - Infect Immun. 1987 Jun;55(6):1369-74 – reference: 5271167 - Proc Natl Acad Sci U S A. 1970 Jun;66(2):322-8 – reference: 12438333 - Infect Immun. 2002 Dec;70(12):6614-20 – reference: 6062006 - J Exp Med. 1967 Nov 1;126(5):959-67 – reference: 15451613 - Vet Immunol Immunopathol. 2004 Nov;102(1-2):33-44 – reference: 15897626 - Exp Anim. 2005 Apr;54(2):163-72 |
| SSID | ssj0029902 |
| Score | 2.2737584 |
| SecondaryResourceType | review_article |
| Snippet | The words 'guinea pig' are synonymous with scientific experimentation, but much less is known about this species than many other laboratory animals. This... The words ‘guinea pig’ are synonymous with scientific experimentation, but much less is known about this species than many other laboratory animals. This... |
| SourceID | pubmedcentral proquest pubmed ingenta fao |
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 324 |
| SubjectTerms | animal disease models Animals bacterial infections Communicable Diseases Communicable Diseases - immunology Communicable Diseases - physiopathology Disease Models, Animal guinea pigs Guinea Pigs - immunology Humans immune response immunology infectious diseases laboratory animals literature reviews Overview physiopathology |
| Title | Guinea Pig as a Model of Infectious Diseases |
| URI | https://www.ingentaconnect.com/content/aalas/cm/2008/00000058/00000004/art00001 https://www.ncbi.nlm.nih.gov/pubmed/18724774 https://www.proquest.com/docview/48128875 https://www.proquest.com/docview/69461410 https://pubmed.ncbi.nlm.nih.gov/PMC2706043 |
| Volume | 58 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Nb9QwEB21PcEBlc-mQPGBa7SJ4yT2sWpZdosESLBSb5a_sqxEs2iT7aG_npnEW7FFnLhFcmwp85zMc-bNDMB7JfJMKlmlntsiFaEqU2OaOrVS1Yb7OsvNoPL9XM0W4uq6vD6AL7tcGJJVxqwiR0oP14-JDVSqqe0nhpILJ-5mQmH7ofIi9cWLF5mYoLmH_9WHcMglKbym86v785eKEsSy4Cl5PnQnjVk_TGPaJ5kPtZJ_OJ_pMTyJrJGdjzA_hYPQPoPH58tNrJwRnkOGgLOPWySNhn1dLZnpmGHU6ewnWzdsHjVX245djiGZ7gUsph--X8zS2A4hbfAM1afo-2tkY95bbqTIfRaCcDI4W1nupbK2yn3AYV6aoHJfc6MyZ4PNaudCLuviJRy16zacALM2SBKWBumUaCqrvPVUx8eW6LGtcAmcoGW0wcfo9OIbp_AmpVwjV0hARXPpuNs7PaCi3U3saRlR0TtU9A6VBGZ_zV25OJ1gIVT0bSlbgUvhYVTmNR5ReKF9aAzaU_dmo5d3usOl3u2w0vhCUJTDtAGtqAVSFvxylv--o1KiInlrAq9GbPWvsbKHRitxgYQ4gXoP9fsbqBj3_ki7-jEU5eZDGaLi9D_M8xoejWoUkhe-gaN-sw1vkfL09gzJ_vzT2bCdfwNuOfx0 |
| linkProvider | Ingenta |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+guinea+pig+as+a+model+of+infectious+diseases&rft.jtitle=Comparative+medicine&rft.au=Padilla-Carlin%2C+Danielle+J&rft.au=McMurray%2C+David+N&rft.au=Hickey%2C+Anthony+J&rft.date=2008-08-01&rft.issn=1532-0820&rft.volume=58&rft.issue=4&rft.spage=324&rft_id=info%3Apmid%2F18724774&rft.externalDocID=18724774 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1532-0820&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1532-0820&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1532-0820&client=summon |